PMS-Olanzapine (2015-02-18)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| C302669 | - Recalling Firm
- Pharmascience Inc.
- 6111 Royalmount Ave., Suite 100
- Montreal
- H4P 2T4
- Quebec
- CANADA
- Marketing Authorization Holder
- Pharmascience Inc.
- 6111 Royalmount Ave., Suite 100
- Montreal
- H4P 2T4
- Quebec
- CANADA
| D. PMS-Olanzapine 10 mg | Tablet | DIN 02303175 | Olanzapine 10 mg |
| C302667 | - Recalling Firm
- Pharmascience Inc.
- 6111 Royalmount Ave., Suite 100
- Montreal
- H4P 2T4
- Quebec
- CANADA
- Marketing Authorization Holder
- Pharmascience Inc.
- 6111 Royalmount Ave., Suite 100
- Montreal
- H4P 2T4
- Quebec
- CANADA
| B. PMS-Olanzapine 5 mg | Tablet | DIN 02303159 | Olanzapine 5 mg |
| C302668 | - Recalling Firm
- Pharmascience Inc.
- 6111 Royalmount Ave., Suite 100
- Montreal
- H4P 2T4
- Quebec
- CANADA
- Marketing Authorization Holder
- Pharmascience Inc.
- 6111 Royalmount Ave., Suite 100
- Montreal
- H4P 2T4
- Quebec
- CANADA
| C. PMS-Olanzapine 7.5 mg | Tablet | DIN 02303167 | Olanzapine 7.5 mg |
| C302666 | - Recalling Firm
- Pharmascience Inc.
- 6111 Royalmount Ave., Suite 100
- Montreal
- H4P 2T4
- Quebec
- CANADA
- Marketing Authorization Holder
- Pharmascience Inc.
- 6111 Royalmount Ave., Suite 100
- Montreal
- H4P 2T4
- Quebec
- CANADA
| A. PMS-Olanzapine 2.5 mg | Tablet | DIN 02303116 | Olanzapine 2.5 mg |
Recalled Products
A. PMS-Olanzapine 2.5 mg
B. PMS-Olanzapine 5 mg
C. PMS-Olanzapine 7.5 mg
D. PMS-Olanzapine 10 mg
This lot is potentially contaminated with foreign tablets (Ondansetron 8mg).